Burkina Faso vs China: Number of new G2D leprosy cases
Burkina Faso
45
in 2024
China
60
in 2024
Burkina Faso rank
23rd
China rank
20th
Number of new G2D leprosy cases over time
- Burkina Faso
- China
How they compare
China currently reports 60 against 45 in Burkina Faso, a difference of 15.
That makes China's figure about 1.3 times Burkina Faso's.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was China ahead.
Burkina Faso ranks 23rd and China ranks 20th of 161 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burkina Faso | China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.12 | 162.38 | 104.25 | China |
| 2020s | 62 | 67.2 | 5.2 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, Burkina Faso or China?
- China, at 60 against 45 in Burkina Faso as of 2024.
- What is the difference in number of new g2d leprosy cases between Burkina Faso and China?
- 15, with China ahead.
- How many years of comparable data are there for Burkina Faso and China?
- 13 years are reported by both, from 2012 to 2024.
- How do Burkina Faso and China rank globally for number of new g2d leprosy cases?
- Burkina Faso ranks 23rd and China ranks 20th of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.